-
COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
-
Jade Khalife, Derrick VanGennep
-
Epidemiol Health. 2021;43:e2021012. Published online February 3, 2021
-
DOI: https://doi.org/10.4178/epih.e2021012
-
-
13,017
View
-
375
Download
-
10
Web of Science
-
10
Crossref
-
Abstract
Summary
PDF
-
Abstract
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread rapidly throughout the human population, the concept of “herd immunity” has attracted the attention of both decision-makers and the general public. In the absence of a vaccine, this entails that a large proportion of the population will be infected to develop immunity that would limit the severity and/or extent of subsequent outbreaks. We argue that adopting such an approach should be avoided for several reasons. There are significant uncertainties about whether achieving herd immunity is possible. If possible, achieving herd immunity would impose a large burden on society. There are gaps in protection, making it difficult to shield the vulnerable. It would defeat the purpose of avoiding harm caused by the virus. Lastly, dozens of countries are showing that containment is possible.
-
Summary
Key Message
Pursuing herd immunity without a vaccine involves numerous uncertainties, is costly in terms of lives and disease, is ineffective, and - being unethical and uncompassionate - is not compatible with human dignity and development.
-
Citations
Citations to this article as recorded by
- Mathematical assessment of the roles of age heterogeneity and vaccination on the dynamics and control of SARS-CoV-2
Binod Pant, Abba B. Gumel Infectious Disease Modelling.2024; 9(3): 828. CrossRef - Assessing the Impact of Risk Factors on Vaccination Uptake Policy Decisions Using a Bayesian Network (BN) Approach
Hafiz Waqar Abbas, Zaman Sajid, Uyen Dao Systems.2024; 12(5): 167. CrossRef - Analyzing natural herd immunity media discourse in the United Kingdom and the United States
Marco Zenone, Jeremy Snyder, Alessandro Marcon, Timothy Caulfield, Veena Sriram PLOS Global Public Health.2022; 2(1): e0000078. CrossRef - Evaluation of science advice during the COVID-19 pandemic in Sweden
Nele Brusselaers, David Steadson, Kelly Bjorklund, Sofia Breland, Jens Stilhoff Sörensen, Andrew Ewing, Sigurd Bergmann, Gunnar Steineck Humanities and Social Sciences Communications.2022;[Epub] CrossRef - Is COVID-19 Herd Immunity Influenced by Population Densities of Cities?
Yuval Arbel, Yifat Arbel, Amichai Kerner, Miryam Kerner Sustainability.2022; 14(16): 10286. CrossRef - Effective strategies against COVID-19 and the importance of infection sequelae
Jade Khalife Global Health Research and Policy.2022;[Epub] CrossRef - Psychological aspects of COVID-19 vaccine in Indian population. Are we still hesitant?
Raza Shaheed, Sourya Acharya, Samarth Shukla, Monika Kesarwani, Neema Acharya Journal of Family Medicine and Primary Care.2022; 11(8): 4280. CrossRef - Herd immunity: challenges and the way forward in Korea
Jiyoung Oh, Sohyun Kim, Boyeong Ryu, Minjoung Shin, Bryan Inho Kim Epidemiology and Health.2021; 43: e2021054. CrossRef - COVID-19 vaccine uptake and vaccine hesitancy in Indian patients with cancer
Vanita Noronha, George Abraham, Suresh Kumar Bondili, Annu Rajpurohit, Rakesh P. Menon, Shreya Gattani, Mehak Trikha, Rajanigandha Tudu, Kishore Kumar Kota, Ajay Kumar Singh, Prahalad Elamarthi, Goutam Santosh Panda, Rahul Kumar Rai, Madala Ravi Krishna, Cancer Research, Statistics, and Treatment.2021; 4(2): 211. CrossRef - COVID-19 vaccine hesitancy in India
Mihir Tusharbhai Dani, Arjun Gurmeet Singh, Pankaj Chaturvedi Cancer Research, Statistics, and Treatment.2021; 4(3): 437. CrossRef
|